NSE ScannerHospitals & Diagnostics · Medical/Nursing Services · NSE: INVICTA · data 2026-10-30
Invicta Diagnostic limited
In plain words
Price: 38.6% below its 52-week high of ₹105.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | — |
| Profit growth, 3 years (yearly) | — |
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
What is the 52-week high and low of Invicta Diagnostic limited?
The 52-week high is ₹105 and the 52-week low is ₹58.1.
Similar companies
Rays of Belief Limited (MOMSBELIEF) · Pramodini Medicare Limited (PRAMODINI) · Lotus Eye Hospital And Institute Ltd (LOTUSEYE) · Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG) · Nidan Laboratories and Healthcare Limited (NIDAN)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open INVICTA in NSE Scanner →